Physician profile
Michael C Sivik
NPI 1578714796
$13,665.11
in general payments reported to CMS, 2019-2025
7 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $150 · 2021: $108 · 2022: $81.55 · 2023: $102 · 2024: $398 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $13K · Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $12,933.00 |
| Food and Beverage | $197.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $12,676.70 | 2022-2025 | |
| American Medical & Dental Supplies,INC. | $505.00 | 2019-2025 | |
| Kulzer, LLC | $197.38 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $150.00 | 2020 | |
| Align Technology, INC. | $95.10 | 2021 | |
| Henry Schein, INC. | $27.85 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $13.08 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sivik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.